GlassScriptPhysician profile
Hala Taha
NPI 1316375926
$2,524.55
in general payments reported to CMS, 2019-2025
7 companies · $849 in 2025
The $849 reported for 2025 was more than what 94% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2021: $108 · 2022: $78.75 · 2023: $300 · 2024: $1,073 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593 · Education: $325 · Travel and Lodging: $294 · Gift: $10.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.56 |
| Education | $325.00 |
| Travel and Lodging | $294.19 |
| Gift | $10.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,888.26 | 2021-2025 | Invisalign, Itero Element 5d Plus Lite, Touch Up |
| Ormco Corporation | $255.73 | 2019-2023 | Spark |
| Envista Holdings Corporation | $249.04 | 2024-2025 | Spark, Insignia, Damon |
| Nobel Biocare USA | $65.68 | 2021-2023 | Nobelactive |
| 3m Company | $27.65 | 2021 | |
| Biohorizons Implant Systems INC. | $27.10 | 2022 | |
| Gc America INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hala Taha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.